mail icon QK, Q. Bertrand, A. Gramfort, J. Salmon, S. Vaiter. Model identification and local linear convergence of coordinate descent. Submitted, 2020

mail icon Q. Bertrand, QK, M. Blondel, S. Vaiter, A. Gramfort, J. Salmon. Implicit differentiation of Lasso-type models for hyperparameter optimization. ICML, 2020

mail icon QK, Samuel Vaiter. Linear Support Vector Regression with Linear Constraints. Submitted, 2019


mail icon C. Reichling, J. Taieb, V. Derangère, QK et al. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study. Gut, 2019

mail icon QK, C. Truntzer, J. Vincent, F. Ghiringhelli. Cell lines and immune classification of glioblastoma define patient’s prognosis. British Journal of Cancer, 2019

mail icon F. Ledys, QK, C. Truntzer, L. Arnould et al. RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer. Journal for Immunotherapy of Cancer, 2018

mail icon JD. Fumet, C. Richard, F. Ledys, QK, et al. Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy. British Journal of Cancer, 2018

mail icon T. Collot, JD. Fumet, QK, J. Vincent et al. Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors. Anticancer Research, 2018